What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer? - Reply

被引：0
|
作者：
Keller, AM [1 ]
机构：
[1] US Oncol Inc, Tulsa, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 25期
关键词：
D O I：
10.1200/JCO.2005.01.2302
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6261 / 6261
页数：1
相关论文
共 50 条
  • [31] Phase II study of irinotecan plus capecitabine in patients with anthracycline and taxane pretreated metastatic breast cancer
    Lee, K. S.
    Ro, J.
    Park, I. H.
    Kim, E. A.
    Nam, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer
    Gunter von Minckwitz
    Walter Jonat
    Peter Fasching
    Andreas du Bois
    Ulrich Kleeberg
    Hans-Joachim Lück
    Erika Kettner
    Jörn Hilfrich
    Wolfgang Eiermann
    Julie Torode
    Andreas Schneeweiss
    [J]. Breast Cancer Research and Treatment, 2005, 89 : 165 - 172
  • [33] Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC).
    Slee, PHTHJ
    Jong, PC
    Jong, RS
    Honkoop, AH
    Coenen, JLLM
    Rodenburg, CJ
    Rooda, SJE
    Douma, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 60S - 60S
  • [34] Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC).
    Slee, PH
    De Jong, RS
    Honkoop, A
    Rodenburg, C
    Rooda, SE
    Coenen, J
    De Jong, PC
    Douma, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 74S - 74S
  • [35] Metronomic Chemotherapy as a Treatment Option for metastatic Breast Cancer
    Krajnak, S.
    Anic, K.
    Almstedt, K.
    Heimes, A-S
    Krajnakova, J.
    Linz, V
    Loewe, A.
    Hasenburg, A.
    Schmidt, M.
    Battista, M. J.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (10) : E109 - E109
  • [36] Palliative chemotherapy with vinorelbine or capecitabine in women with anthracycline and taxane refractory metastatic breast cancer.
    Clemons, MJ
    Verma, S
    Leung, V
    Dranitsaris, G
    Shalaby, I
    Oldfield, S
    Charbonneau, F
    Giotis, A
    Petrella, T
    Trudeau, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 70S - 70S
  • [37] Combination anthracycline and taxane chemotherapy in first line metastatic breast cancer: a meta-analysis.
    Petrella, TM
    Trudeau, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S128 - S128
  • [38] Eribulin: a new treatment option in metastatic breast cancer heavily pretreated?
    Goncalves, Anthony
    [J]. BULLETIN DU CANCER, 2011, 98 (05) : 455 - 455
  • [39] Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
    Park, Ji Soo
    Jeung, Hei-Cheul
    Rha, Sun Young
    Ahn, Joong Bae
    Kang, Beodeul
    Chon, Hong Jae
    Hong, Min Hee
    Lim, Seungtaek
    Yang, Woo Ick
    Nam, Chung Mo
    Chung, Hyun Cheol
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 799 - 808
  • [40] High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer
    V. Heinemann
    H. J. Stemmler
    A. Wohlrab
    D. Bosse
    C. Losem
    S. Kahlert
    G. Rauthe
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 57 : 640 - 646
12345